Observer Variation in Assessment of Liver Biopsies of Alcoholic Patients
Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Jean‐Claude Chaput(Hôpital Antoine-Béclère), E. Martin(Institut de Cancérologie de l'Ouest), Sylvie Naveau(Bicêtre Hospital), Thierry Poynard(Inserm), Hélène Agostini(Hôpital Antoine-Béclère)
Cited by 95
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
Liver extracellular matrix in health and disease
|The Journal of Pathology|2003|299